Earnings — page 18
OraSure Core Sales Hold After Two-Quarter Slide
Second-quarter revenue of $30.6 million rose 9.7% from the prior quarter and sat above the company's guidance range.
Oportun Raises Full-Year Ebitda Outlook After Margin Expansion
Adjusted EBITDA reached $49 million in the second quarter, and the company lifted its full-year range 6% at the midpoint to $160 million to $175 million.
BeOne Raises Outlook as Operating Margin Widens
Free cash flow nearly doubled to $435 million in the second quarter.
Orion Raises Free Cash Flow Outlook After Specialty Rebound
Second-quarter Adjusted EBITDA reached $58 million, and the company lifted its 2026 free cash flow range to a $10 million outflow to $20 million inflow.
New York Times Lifts Profit as Digital Subscription Growth Accelerates
Revenue rose 11.2% to $762.5 million as subscriptions and advertising advanced.
Lightbridge Removes First Irradiated Fuel Samples From Reactor
Cash and cash equivalents were $237.5 million at June 30, 2026, as Lightbridge posted a $5.8 million net loss for the quarter.
LifeMD Cuts 2026 Profit Outlook After GLP-1 Shift
Second-quarter revenue was $47.3 million and the company now sees full-year adjusted EBITDA of negative $6.0 million to breakeven.
LCI Lifts Profit as Aftermarket Offsets RV Slump
Adjusted net sales declined 4.5% to $1.057 billion after accounting for expected tariff-refund pass-throughs.
CS Disco Raises Low End of 2026 Revenue Outlook
Second-quarter revenue was $43.1 million, up 13% from a year earlier, as the company lifted the low end of its full-year total-revenue range.
Standard BioTools Drops 2026 Revenue Outlook Amid Treeline Merger
Second-quarter revenue was $20.1 million as the company said it is on track to close the Treeline Biosciences combination before year-end.
Kaltura Restores Year-Over-Year Revenue Growth
Second-quarter revenue was $46.9 million, up 5% from a year earlier, after a 5% decline in the first quarter, and the company said it beat the high end of its guidance.
Kraft Heinz Posts $6.4 Billion Operating Loss on Impairment Charge
A $7.4 billion non-cash impairment drove Kraft Heinz to a GAAP operating loss in the quarter, even as management narrowed its full-year sales-decline forecast.
Inspired Entertainment's Adjusted EBITDA Margin Reaches 45%
Adjusted EBITDA reached $27.1 million in the second quarter, up 14% from the prior quarter, as the company reaffirmed a 2026 target of $112 million to $118 million.
Immuneering Doses MAPKeeper 301 After ASCO Survival Data
The company reported 17.3-month median overall survival in 55 first-line pancreatic cancer patients on atebimetinib plus mGnP, with cash of $182.7 million and runway still expected into 2029.
ISG Posts Highest Quarterly Revenue Since 2023
Second-quarter revenue reached $65.5 million, up 6.4% from a year earlier, as year-over-year growth accelerated from the first quarter's 3% pace.
Holley Completes Restoration Brand Sales
Net sales rose 3.2% to $172.0 million as the company booked a $28.3 million loss on the sale of non-core assets.
Hudson Cuts 2026 Gross-Margin Target After Volume Gain
Second-quarter revenue reached $78.3 million as sales volume rose 12% and selling prices fell 6%.
Hamilton Beach Restores Sales After a First-Quarter Drop
Second-quarter revenue rose 11.6% to $142.6 million as U.S. Consumer volumes recovered and IEEPA tariff refunds lifted reported gross margin to 54.3%.
FTAI Infrastructure Posts Record Rail Earnings
Railroad Adjusted EBITDA reached $42.4 million as the company booked $76.1 million of group Adjusted EBITDA and a $63.2 million impairment.
Energy Recovery's Megaproject Sales Collapse After Iran War
Second-quarter revenue fell 57% to $12.0 million as megaproject sales dropped 82% and the company posted a $3.2 million net loss.
Emergent Cuts Full-Year Outlook After Naloxone Impairment
Second-quarter revenue reached $234.3 million as medical countermeasures rose, while the company booked a $191.3 million NARCAN impairment and lowered full-year revenue guidance to $645 million to $675 million.
Disney Profit Growth Accelerates as Experiences Lead
Quarterly revenue rose 7% to $25.25 billion, holding its prior-quarter growth rate.
DHI Raises Dice Margin Outlook, Reaffirms Revenue Guidance
ClearanceJobs bookings rose 24% to $14.3 million as the company lifted Dice's full-year Adjusted EBITDA margin target to 24% from 22%.
CVS Health Raises Full-Year Profit Guidance on Health Care Gains
The healthcare giant increased its full-year 2026 adjusted EPS guidance to a range of $7.90 to $8.10.
Cencora Raises Outlook as OneOncology Expands Margins
Fiscal third-quarter revenue rose 5.1% to $84.8 billion as specialty-drug volumes increased.
Coherus Oncology Restores LOQTORZI Growth After Weather-Weighed Quarter
LOQTORZI net revenue reached $13.6 million in the second quarter, up 15% from $11.8 million in the first quarter.
BillionToOne’s Revenue Growth Slowed for a Second Straight Quarter
The molecular diagnostics company reported $109.4 million in second-quarter revenue and maintained its full-year forecast after two successive increases.
BioAge Doses First Patient in BGE-102 Phase 2 Trial
The company said QUELL-CV topline data are expected in the second half of 2026, with cash of about $381.3 million funding operations through 2029.
Biodesix Test Volume Growth Accelerates
Second-quarter revenue was $26.9 million, up 34%, as diagnostic test volumes rose 38% to 20,900.
Alto Extends Profit Streak to a Fourth Quarter
Second-quarter net income attributable to common stockholders was $11.4 million, or $0.15 a share, after a $1.9 million gross loss a year earlier.
Akebia Turns to a Loss as Auryxia Recedes
Vafseo net product sales reached $21.3 million in the second quarter, up 34% from the first quarter, as more than 10,500 patients were on therapy.
Exagen Raises 2026 Revenue Outlook After Record Quarter
Second-quarter revenue reached a record $19.9 million as the company lifted full-year guidance to $72 million to $75 million.
Wayfair Revenue Growth Accelerates as US Sales Gain Momentum
The e-commerce retailer reported total net revenue of $3.5 billion for the second quarter.
USANA Swings to Loss After Hiya Goodwill Impairment
The health-products company booked a $29.1 million preliminary Hiya goodwill charge and cut fiscal 2026 sales guidance to $910 million.
Wheels Up Completes Fleet Modernization as Charter Bookings Fall
GAAP revenue was $182.0 million in the second quarter, down 4% year over year, while Adjusted EBITDAR loss narrowed 27% to $19.9 million.
Superior Group Confirms 2026 Outlook After Apparel Impairment
Adjusted earnings were $0.21 a share after a $2.6 million Healthcare Apparel tradename charge that left reported profit at $0.08 a share.
Rockwell Automation Raises Full-Year Outlook as Software Sales Climb
The industrial automation provider increased its fiscal 2026 diluted EPS guidance to a range of $12.72 to $13.02.
Pfizer Swings to Loss on $4.3 Billion Impairment as Growth Slows
Pfizer posted a reported loss of $(0.04) a share in the second quarter after taking $4.3 billion in non-cash intangible impairments, even as it raised full-year revenue guidance by $500 million.
PAMT Reverses First-Quarter Revenue Decline
Second-quarter operating revenue reached $164.7 million as the truckload carrier booked a $3.1 million auto-liability accrual.
Niagen Launches NB4168 Drug Candidate and Telehealth Platform
Second-quarter net sales were $29.8 million, including $24.2 million from Tru Niagen, as the company introduced NB4168 and a Niagen Plus telehealth channel.
Merck Raises Sales Outlook as Acquisition Charge Drives Loss
Quarterly sales increased to $16.607 billion as cancer-drug demand offset declining diabetes revenue.
McDonald’s Sales Growth Slows as U.S. Traffic Turns Negative
Second-quarter revenue increased 4% to $7.10 billion as growth moderated across McDonald’s major markets.
LoanDepot Narrows Loss as Home Equity Mix Lifts Margin
Second-quarter revenue reached $337 million as pull-through weighted gain on sale margin rose to 345 basis points.
InfuSystem Oncology Crosses $20 Million in a Quarter
Net revenues reached $36.9 million, up 2.6% from a year earlier, and Adjusted EBITDA rose 7.6% to $8.6 million.
Idexx Raises Outlook as Margins Widen
Second-quarter revenue reached $1.217 billion as stronger profitability supported a higher full-year forecast.
Horizon NAV Falls After Single-Name Unrealized Losses
Net asset value was $6.23 a share at June 30, 2026, after $38.5 million of net unrealized depreciation, or $0.59 a share.
8x8 Extends Revenue Growth Into Fiscal 2027
The communications platform posted record service revenue of $185.3 million and total revenue of $190.2 million in the quarter ended June 30, 2026.
Crexendo's Second-Quarter Revenue Growth Accelerates
Total revenue rose 49% to $24.6 million as service sales and adjusted EBITDA expanded after the Estech Systems deal.
Core Molding Gross Margin Reaches 20.3% of Sales
Second-quarter net revenue was $62.7 million as truck product sales stayed soft and tooling project revenue fell to $1.8 million.
Caterpillar hits record quarterly revenue as construction demand accelerates
The industrial manufacturer generated $20.5 billion in sales during the second quarter, the first time the company has exceeded $20 billion in a single period.